[[FCGR2B]]

CATEGORIES: Glycoproteins, Clusters of differentiation, Fc receptors

Low affinity immunoglobulin gamma Fc region receptor II-b is a protein that, in humans, is encoded by the FCGR2B gene. FCGR2B (CD32B) is a "low affinity" receptor for Immunoglobulin G (IgG). Mutation in the gene in humans leads to a lupus phenotype. [tpl]cite journal | author = Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV | title = Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination | journal = Science | volume = 248 | issue = 4956 | pages = 732–5 |date=Jun 1990 | pmid = 2139735 | pmc =  | doi =10.1126/science.2139735  [/tpl][tpl]cite web | title = Entrez Gene: FCGR2B Fc fragment of IgG, low affinity IIb, receptor (CD32)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2213| accessdate = [/tpl] The cytoplasmic part of this receptor contains an immunoreceptor tyrosine-based inhibitory motif, in contrast to the activating isoform, FCGR2A (CD32A).

==Function==

The inhibitory CD32B is expressed on B cells and myeloid dendritic cells.[tpl]cite journal|title=Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions|journal=J Clin Invest|year=2005|volume=115|issue=10|pages=2914-23|doi=10.1172/JCI24772|pmid=16167082|author=Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW|pmc=1201664[/tpl] [tpl]open access[/tpl] [tpl]link note|note=Free full text[/tpl] Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation.  CD32B may also be a target for monoclonal antibody therapy for malignancies.[tpl]cite journal|author=Rankin CT, Veri MC, Gorlatov S, Tuaillon N, Burke S, Huang L, Inzunza HD, Li H, Thomas S, Johnson S, Stavenhagen J, Koenig S, Bonvini E |url=http://bloodjournal.hematologylibrary.org/cgi/pmidlookup?view=long&pmid=16757681 |title=CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma |journal=Blood |volume=108 |issue=7 |pages=2384-91 |year=2006 |doi=10.1182/blood-2006-05-020602 |pmid=16757681[/tpl] [tpl]open access[/tpl] [tpl]link note|note=Free full text[/tpl][tpl]cite journal|author=Zhou P, Comenzo RL, Olshen AB, Bonvini E, Koenig S, Maslak PG, Fleisher M, Hoffman J, Jhanwar S, Young JW, Nimer SD, Boruchov AM |title=CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy |journal=Blood |volume=111 |issue=7 |pages=3403-6 |year=2008 |doi=10.1182/blood-2007-11-125526 |pmid=18216299 |pmc=2275009[/tpl] [tpl]open access[/tpl] [tpl]link note|note=Free full text[/tpl]

==See also==

==References==

==Further reading==

==External links==


